Mytrex Health Technologies, Inc. (TPEX:4431)

TPEX:4431 Revenue

Mytrex Health Technologies had revenue of 1.06B TWD in the half year ending June 30, 2026, with 32.62% growth. This brings the company's total for the last twelve months to 2.05B, up 7.43% year-over-year. In the year 2025, Mytrex Health Technologies had annual revenue of 1.94B with 10.59% growth. That makes Mytrex Health Technologies the 26,212th largest company in the world by revenue and 1,191st in Taiwan.

• Revenue (ttm): 2.05B
• Revenue Growth: +7.43%
• P/S Ratio: 0.38
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 770.90M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicine Distribution Division 1.77B 90.8%
• Technological Material Business Segment 129.71M 6.7%
• Medical Biotechnology Business Sector (Including Medical Sanitation Materials) 49.77M 2.6%
• Other Department 11.00K 0.0%

By Geography

Chart

• Asia 1.92B 98.9%
• Other countries 16.38M 0.8%
• Europe 4.28M 0.2%

Fiscal year ended Dec 31, 2025 See the full TPEX:4431 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.94B	186.16M	10.59%
Dec 31, 2024	1.76B	465.72M	36.02%
Dec 31, 2023	1.29B	-178.58M	-12.14%
Dec 31, 2022	1.47B	1.18B	404.61%
Dec 31, 2021	291.62M	-732.02M	-71.51%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 22, 2026

Data Sources Report a data error